Arizona State Retirement System Iveric Bio, Inc. Transaction History

Arizona State Retirement System

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$26.24 - $39.63 $6,638 - $10,026	-253 Reduced 0.77%	32,768 $1.29 Million
Q1 2023 Apr 27, 2023	BUY	$18.67 - $24.56 $16,765 - $22,054	898 Added 2.8%	33,021 $803,000
Q4 2022 Feb 07, 2023	BUY	$17.24 - $23.95 $172,003 - $238,949	9,977 Added 45.05%	32,123 $687,000
Q3 2022 Nov 07, 2022	BUY	$9.4 - $18.59 $3,741 - $7,398	398 Added 1.83%	22,146 $397,000
Q2 2022 Jul 28, 2022	BUY	$9.12 - $18.9 $501 - $1,039	55 Added 0.25%	21,748 $209,000
Q1 2022 May 04, 2022	BUY	$12.15 - $16.83 $25,478 - $35,292	2,097 Added 10.7%	21,693 $365,000
Q4 2021 Feb 04, 2022	BUY	$13.83 - $18.78 $21,477 - $29,165	1,553 Added 8.61%	19,596 $328,000
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $24,285 - $60,112	3,435 Added 23.51%	18,043 $293,000
Q2 2021 Aug 02, 2021	SELL	$5.69 - $7.17 $35,568 - $44,819	-6,251 Reduced 29.97%	14,608 $92,000
Q1 2021 May 06, 2021	BUY	$5.08 - $6.89 $105,963 - $143,718	20,859 New	20,859 $129,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.